SEC Form 4 · accession 0001179110-15-016821
Allergan plc · AGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Bisaro
Officer — Exec Chairman · Director
Period of report
Jul 31, 2015
Accepted (ET)
Dec 30, 2015 · 6:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001578845
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value $0.0001F1 | Jul 31, 2015 | G | 120,000 | $0.00 | D | 120,000 | I | Paul Investment LLC |
| Ordinary Shares, par value $0.0001 | holding | — | — | — | 301,755 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On June 9, 2015, Mr. Bisaro transferred 120,000 shares to Paul Bisaro LLC ("LLC"), an LLC in which Mr. Bisaro retains an ownership interest and might be deemed to have or share investment control. Subsequently 99% of the LLC interests were transferred to four (4) GRATs of which the remainder beneficiaries are Mr. Bisaro's children. Mr. Bisaro may be deemed to continue to beneficially own the shares that were transferred to the LLC but he disclaims beneficial ownership of all such shares.